| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/2010 | US20100190735 Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis |
| 07/29/2010 | US20100190734 Method of treating dry eye disease with azithromycin |
| 07/29/2010 | US20100190733 Methods of Treating Muscular Dystrophies |
| 07/29/2010 | US20100190732 Use of pterosin compounds for treating diabetes and obesity |
| 07/29/2010 | US20100190731 Methods for treating acute myocardial infarctions and associated disorders |
| 07/29/2010 | US20100190730 Application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression |
| 07/29/2010 | US20100190729 Composition for treating atopic dermatitis comprising hirsutanonol or oregonin as an active ingredient |
| 07/29/2010 | US20100190728 Synthesis Of Metabolically Stable Analgesics, Pain Medications And Other Agents |
| 07/29/2010 | US20100190727 Use of monosaccharides and composition therefor |
| 07/29/2010 | US20100190726 Novel Phyllanthus Extract |
| 07/29/2010 | US20100190725 Amino acid derivatives |
| 07/29/2010 | US20100190714 RNAi Inhibition of Alpha-ENaC Expression |
| 07/29/2010 | US20100190705 Suppression of glial fibrillary acidic protein |
| 07/29/2010 | US20100190702 Compositions and Methods of Treating Neoplasia |
| 07/29/2010 | US20100190696 Treatment of t-cell mediated diseases |
| 07/29/2010 | US20100190694 Methods for identifying patients who will respond well to cancer treatment |
| 07/29/2010 | US20100190693 Method for screening compounds & uses therefor |
| 07/29/2010 | US20100190692 Methods for reducing gnrh-positive tumor cell proliferation |
| 07/29/2010 | US20100190689 Compositions and methods related to protein displacement therapy for myotonic distrophy |
| 07/29/2010 | US20100190688 Tetrapeptide analogs |
| 07/29/2010 | US20100190687 Pyrimidinone derivatives and methods of use thereof |
| 07/29/2010 | US20100190686 Novel secreted proteins of adipocytes for diagnostic purposes |
| 07/29/2010 | US20100190685 Prognostic factor in sarcoma, and metastasis inhibitor |
| 07/29/2010 | US20100190684 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity |
| 07/29/2010 | US20100190645 Synergistic fungicidal active compound combinations comprising formononetin |
| 07/29/2010 | US20100190172 detecting specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease |
| 07/29/2010 | US20100189829 Cocoa extract and use thereof |
| 07/29/2010 | US20100189824 Triterpene compositions and methods for use thereof |
| 07/29/2010 | US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
| 07/29/2010 | US20100189818 Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
| 07/29/2010 | US20100189817 Treating Glaucoma |
| 07/29/2010 | US20100189815 Colon cleansing compositions and methods |
| 07/29/2010 | US20100189808 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes |
| 07/29/2010 | US20100189797 Oral antidepressant formulation |
| 07/29/2010 | US20100189796 Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile |
| 07/29/2010 | US20100189795 Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions |
| 07/29/2010 | US20100189793 Electrophoretic transdermal delivery system |
| 07/29/2010 | US20100189792 In vivo gene transfer methods for wound healing |
| 07/29/2010 | US20100189791 Delayed release rasagiline malate formulation |
| 07/29/2010 | US20100189789 Micronized Tanaproget, Compositions, and Methods of Preparing the Same |
| 07/29/2010 | US20100189788 Delayed release rasagiline base formulation |
| 07/29/2010 | US20100189787 Delayed release rasagiline citrate formulation |
| 07/29/2010 | US20100189786 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same |
| 07/29/2010 | US20100189785 Use of D-ribose for fatigued subjects |
| 07/29/2010 | US20100189784 Use of Alkylphophocholine in Combination with Antitumor Medication for the Treatment of Benign and Malignant Oncoses in Humans and Mammals |
| 07/29/2010 | US20100189783 Relating to anti-hiv tablet formulations |
| 07/29/2010 | US20100189782 Compositions Comprising Carisoprodol and Methods of Use Thereof |
| 07/29/2010 | US20100189781 Alkoxyalkyl s-prenylthiosalicylates for treatment of cancer |
| 07/29/2010 | US20100189780 Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier |
| 07/29/2010 | US20100189779 In vivo device, system and usage thereof |
| 07/29/2010 | US20100189778 Opioid delivery system |
| 07/29/2010 | US20100189775 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 07/29/2010 | US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/29/2010 | US20100189771 Fixed ratio drug combination treatments for solid tumors |
| 07/29/2010 | US20100189770 Bioerodible patch |
| 07/29/2010 | US20100189769 Polypeptide Films and Methods |
| 07/29/2010 | US20100189765 Implantable ocular drug delivery device and methods |
| 07/29/2010 | US20100189764 Bioactive mesh |
| 07/29/2010 | US20100189762 Triarylmethane analogs and their use in treating cancers |
| 07/29/2010 | US20100189761 Methods for Prevention and/or Treatment of Capsular Contracture |
| 07/29/2010 | US20100189758 Coating containing pegylated hyaluronic acid and a pegylated non-hyaluronic acid polymer |
| 07/29/2010 | US20100189757 Drug depot implant designs and methods of implantation |
| 07/29/2010 | US20100189755 Dryer Sheets and a Method for Treating Skin |
| 07/29/2010 | US20100189726 Lpaat-beta inhibitors and uses thereof |
| 07/29/2010 | US20100189725 P53 modulator and cancer target |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189713 Use of Semaphorin 6A for Promoting Myelination and Oligodendrocyte Differentiation |
| 07/29/2010 | US20100189708 Hydroxy piperidine derivatives to treat gaucher disease |
| 07/29/2010 | US20100189704 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose |
| 07/29/2010 | US20100189702 Compositions and methods for restoring bacterial flora |
| 07/29/2010 | US20100189701 Methods and compositions to treat arrhythmias |
| 07/29/2010 | US20100189698 Treatment or prophylaxis of a neurological or neuropsychiatric disorders via ocular administration |
| 07/29/2010 | US20100189687 Modulators of pharmacokinetic properties of therapeutics |
| 07/29/2010 | US20100189685 Antiviral Drugs for Treatment or Prevention of Dengue Infection |
| 07/29/2010 | US20100189684 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/29/2010 | US20100189683 Pulsatile Dosing of Gossypol for Treatment of Disease |
| 07/29/2010 | US20100189680 Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7 |
| 07/29/2010 | US20100189679 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
| 07/29/2010 | US20100189676 Cosmetic preparation comprising silicone |
| 07/29/2010 | US20100189675 Cosmetic use of an imidopercarboxylic acid derivative as desquamating agent |
| 07/29/2010 | US20100189669 Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives |
| 07/29/2010 | US20100189665 Cosmetic Preparations Containing Hydrocarbons |
| 07/29/2010 | US20100189653 Pyrone analogs for therapeutic treatment |
| 07/29/2010 | US20100189649 Monoclonal antibodies to activated erbb family members and methods of use |
| 07/29/2010 | US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof |
| 07/29/2010 | US20100189646 Carbazole Derivatives as Functional 5-HT6 Ligands |
| 07/29/2010 | US20100189644 Arginase inhibitors and methods of use |
| 07/29/2010 | US20100189596 Composite emulsifier, an emulsion prepared from it and the preparation method thereof |
| 07/29/2010 | DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses |
| 07/29/2010 | DE102009006228A1 Liposomal composition, useful to treat e.g. brain metastases, comprises liposomal vesicle, where the vesicles consist of a base lipid, a membrane stabilizer, a helper lipid and a charge carrier, and contain a cytostatic agent and a ligand |
| 07/29/2010 | CA2754007A1 Pharmaceutical composition comprising racemic aminopterin |
| 07/29/2010 | CA2750777A1 Bicyclic heterocyclic spiro compounds |
| 07/29/2010 | CA2750761A1 Methods of treating muscular dystrophies |
| 07/29/2010 | CA2750639A1 Hedgehog pathway inhibitors |
| 07/29/2010 | CA2750636A1 Rosacea treatments and kits for performing them |
| 07/29/2010 | CA2750599A1 Use of deferiprone for treatment and prevention of iron-related eye disorders |
| 07/29/2010 | CA2750582A1 Method for the prophylaxis or treatment of flushing |
| 07/29/2010 | CA2750561A1 Compositions and methods for silencing apolipoprotein c-iii expression |
| 07/29/2010 | CA2750530A1 Estrus synchronization preparations and effective cidr-less protocols |
| 07/29/2010 | CA2750510A1 Treatment of neurotrophic factor mediated disorders |